Digital Cognition Technologies

Developed a clinically validated digital cognitive assessment tool—DCTclock—that enables earlier and more sensitive detection of cognitive impairment than traditional pen-and-paper tests. The technology was based on over a decade of R&D at MIT and Lahey Hospital & Medical Center. The company was acquired by Linus Health in 2020. Clinical results demonstrated improved sensitivity for detecting presymptomatic or early-stage cognitive decline compared to legacy methods. Post-acquisition by Linus Health in 2020, the technology has been integrated into a broader digital brain health platform. FDA Class II clearance for the core product. Used in clinical practice settings as well as research/life sciences applications.